Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity

AIMS: In idiopathic inflammatory myopathies (IIM), disease activity is difficult to assess, and IIM may induce severe muscle damage, especially in immune‐mediated necrotising myopathies (IMNM) and inclusion body myositis (IBM). We hypothesise that myostatin, a negative regulator of muscle mass, coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahoudeau, Alexandrine, Anquetil, Céline, Tawara, Nozomu, Khademian, Hossein, Amelin, Damien, Bolko, Loïs, Silvestro, Marco, Cin, Julian Dal, Tendrel, Bérénice, Tardif, Virginie, Mariampillai, Kubéraka, Butler‐Browne, Gillian, Benveniste, Olivier, Allenbach, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092350/
https://www.ncbi.nlm.nih.gov/pubmed/36168256
http://dx.doi.org/10.1111/nan.12849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092350/
https://www.ncbi.nlm.nih.gov/pubmed/36168256
http://dx.doi.org/10.1111/nan.12849

Ejemplares similares